Cargando…
Potential Pathways to Restore β-Cell Mass: Pluripotent Stem Cells, Reprogramming, and Endogenous Regeneration
Currently available β-cell replacement therapies for patients with diabetes, including islet and pancreas transplantation, are largely successful in restoring normal glucose metabolism, but the scarcity of organ donors restricts their more widespread use. To solve this supply problem, several differ...
Autores principales: | Baiu, Dana, Merriam, Fabiola, Odorico, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167041/ https://www.ncbi.nlm.nih.gov/pubmed/21800022 http://dx.doi.org/10.1007/s11892-011-0218-7 |
Ejemplares similares
-
Endogenous retinal neural stem cell reprogramming for neuronal regeneration
por: Madelaine, Romain, et al.
Publicado: (2017) -
Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
por: Sadahiro, Taketaro
Publicado: (2019) -
Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells
por: Klawitter, Sabine, et al.
Publicado: (2016) -
Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation
por: Jasra, Ila Tewari, et al.
Publicado: (2023) -
Reprogramming Primordial Germ Cells into Pluripotent Stem Cells
por: Durcova-Hills, Gabriela, et al.
Publicado: (2008)